227 related articles for article (PubMed ID: 25242053)
1. The expression of four genes as a prognostic classifier for stage I lung adenocarcinoma in 12 independent cohorts.
Okayama H; Schetter AJ; Ishigame T; Robles AI; Kohno T; Yokota J; Takenoshita S; Harris CC
Cancer Epidemiol Biomarkers Prev; 2014 Dec; 23(12):2884-94. PubMed ID: 25242053
[TBL] [Abstract][Full Text] [Related]
2. Combination of protein coding and noncoding gene expression as a robust prognostic classifier in stage I lung adenocarcinoma.
Akagi I; Okayama H; Schetter AJ; Robles AI; Kohno T; Bowman ED; Kazandjian D; Welsh JA; Oue N; Saito M; Miyashita M; Uchida E; Takizawa T; Takenoshita S; Skaug V; Mollerup S; Haugen A; Yokota J; Harris CC
Cancer Res; 2013 Jul; 73(13):3821-32. PubMed ID: 23639940
[TBL] [Abstract][Full Text] [Related]
3. An Integrated Prognostic Classifier for Stage I Lung Adenocarcinoma Based on mRNA, microRNA, and DNA Methylation Biomarkers.
Robles AI; Arai E; Mathé EA; Okayama H; Schetter AJ; Brown D; Petersen D; Bowman ED; Noro R; Welsh JA; Edelman DC; Stevenson HS; Wang Y; Tsuchiya N; Kohno T; Skaug V; Mollerup S; Haugen A; Meltzer PS; Yokota J; Kanai Y; Harris CC
J Thorac Oncol; 2015 Jul; 10(7):1037-48. PubMed ID: 26134223
[TBL] [Abstract][Full Text] [Related]
4. A Two-Gene Prognostic Classifier for Early-Stage Lung Squamous Cell Carcinoma in Multiple Large-Scale and Geographically Diverse Cohorts.
Noro R; Ishigame T; Walsh N; Shiraishi K; Robles AI; Ryan BM; Schetter AJ; Bowman ED; Welsh JA; Seike M; Gemma A; Skaug V; Mollerup S; Haugen A; Yokota J; Kohno T; Harris CC
J Thorac Oncol; 2017 Jan; 12(1):65-76. PubMed ID: 27613525
[TBL] [Abstract][Full Text] [Related]
5. A gene expression-based single sample predictor of lung adenocarcinoma molecular subtype and prognosis.
Liljedahl H; Karlsson A; Oskarsdottir GN; Salomonsson A; Brunnström H; Erlingsdottir G; Jönsson M; Isaksson S; Arbajian E; Ortiz-Villalón C; Hussein A; Bergman B; Vikström A; Monsef N; Branden E; Koyi H; de Petris L; Patthey A; Behndig AF; Johansson M; Planck M; Staaf J
Int J Cancer; 2021 Jan; 148(1):238-251. PubMed ID: 32745259
[TBL] [Abstract][Full Text] [Related]
6. HOXA9 methylation and blood vessel invasion in FFPE tissues for prognostic stratification of stage I lung adenocarcinoma patients.
Lissa D; Ishigame T; Noro R; Tucker MJ; Bliskovsky V; Shema S; Beck JA; Bowman ED; Harris CC; Robles AI
Lung Cancer; 2018 Aug; 122():151-159. PubMed ID: 30032824
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
8. Validation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage IA patients.
Der SD; Sykes J; Pintilie M; Zhu CQ; Strumpf D; Liu N; Jurisica I; Shepherd FA; Tsao MS
J Thorac Oncol; 2014 Jan; 9(1):59-64. PubMed ID: 24305008
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma.
Eguchi T; Kadota K; Chaft J; Evans B; Kidd J; Tan KS; Dycoco J; Kolquist K; Davis T; Hamilton SA; Yager K; Jones JT; Travis WD; Jones DR; Hartman AR; Adusumilli PS
Oncotarget; 2016 Jun; 7(23):35241-56. PubMed ID: 27153551
[TBL] [Abstract][Full Text] [Related]
10. A five-gene and corresponding protein signature for stage-I lung adenocarcinoma prognosis.
Kadara H; Behrens C; Yuan P; Solis L; Liu D; Gu X; Minna JD; Lee JJ; Kim E; Hong WK; Wistuba II; Lotan R
Clin Cancer Res; 2011 Mar; 17(6):1490-501. PubMed ID: 21163870
[TBL] [Abstract][Full Text] [Related]
11. Validation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinoma.
Wistuba II; Behrens C; Lombardi F; Wagner S; Fujimoto J; Raso MG; Spaggiari L; Galetta D; Riley R; Hughes E; Reid J; Sangale Z; Swisher SG; Kalhor N; Moran CA; Gutin A; Lanchbury JS; Barberis M; Kim ES
Clin Cancer Res; 2013 Nov; 19(22):6261-71. PubMed ID: 24048333
[TBL] [Abstract][Full Text] [Related]
12. An Aggressive Subtype of Stage I Lung Adenocarcinoma with Molecular and Prognostic Characteristics Typical of Advanced Lung Cancers.
Dama E; Melocchi V; Dezi F; Pirroni S; Carletti RM; Brambilla D; Bertalot G; Casiraghi M; Maisonneuve P; Barberis M; Viale G; Vecchi M; Spaggiari L; Bianchi F; Di Fiore PP
Clin Cancer Res; 2017 Jan; 23(1):62-72. PubMed ID: 27358486
[TBL] [Abstract][Full Text] [Related]
13. A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients.
Martínez-Terroba E; Behrens C; de Miguel FJ; Agorreta J; Monsó E; Millares L; Sainz C; Mesa-Guzman M; Pérez-Gracia JL; Lozano MD; Zulueta JJ; Pio R; Wistuba II; Montuenga LM; Pajares MJ
J Pathol; 2018 Aug; 245(4):421-432. PubMed ID: 29756233
[TBL] [Abstract][Full Text] [Related]
14. Gene-expression signature predicts postoperative recurrence in stage I non-small cell lung cancer patients.
Lu Y; Wang L; Liu P; Yang P; You M
PLoS One; 2012; 7(1):e30880. PubMed ID: 22292069
[TBL] [Abstract][Full Text] [Related]
15. Role for High-Affinity IgE Receptor in Prognosis of Lung Adenocarcinoma Patients.
Ly D; Zhu CQ; Cabanero M; Tsao MS; Zhang L
Cancer Immunol Res; 2017 Sep; 5(9):821-829. PubMed ID: 28775209
[TBL] [Abstract][Full Text] [Related]
16. Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer.
Gentles AJ; Bratman SV; Lee LJ; Harris JP; Feng W; Nair RV; Shultz DB; Nair VS; Hoang CD; West RB; Plevritis SK; Alizadeh AA; Diehn M
J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26286589
[TBL] [Abstract][Full Text] [Related]
17. Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimators.
Rakha E; Pajares MJ; Ilie M; Pio R; Echeveste J; Hughes E; Soomro I; Long E; Idoate MA; Wagner S; Lanchbury JS; Baldwin DR; Hofman P; Montuenga LM
Eur J Cancer; 2015 Sep; 51(14):1897-903. PubMed ID: 26235745
[TBL] [Abstract][Full Text] [Related]
18. Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinoma.
Zhou M; Xu W; Yue X; Zhao H; Wang Z; Shi H; Cheng L; Sun J
Oncotarget; 2016 May; 7(20):29720-38. PubMed ID: 27105492
[TBL] [Abstract][Full Text] [Related]
19. Prognostic signature of early lung adenocarcinoma based on the expression of ribonucleic acid metabolism-related genes.
Pio R; Agorreta J; Montuenga LM
J Thorac Cardiovasc Surg; 2015 Oct; 150(4):986-92.e1-11. PubMed ID: 26162308
[TBL] [Abstract][Full Text] [Related]
20. Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma.
Shukla S; Evans JR; Malik R; Feng FY; Dhanasekaran SM; Cao X; Chen G; Beer DG; Jiang H; Chinnaiyan AM
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27707839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
